Genomics for All: International Open Science Genomics Projects and Capacity Building in the Developing World

Abstract

Genomic medicine applications have the potential to considerably improve health care in developing countries in the coming years. However, if developing countries do not improve their capacity for research and development (R&D) in the field, they might be left out of the genomics revolution. Large-scale and widely accessible databases for storing and analyzing genomic data are crucial tools for the advancement of genomic medicine. Building developing countries' capacity in genomics is accordingly closely linked to their involvement in international human genomics research initiatives. The purpose of this paper is to conduct a pilot study on the impact of international open science genomics projects on capacity building in R&D in developing countries. Using indicators we developed in previous work to measure the performance of international open science genomics projects, we analyse the policies and practices of four key projects in the field: the International HapMap Project, the Human Heredity and Health in Africa Initiative, the Malaria Genomic Epidemiology Network and the Structural Genomics Consortium. The results show that these projects play an important role in genomics capacity building in developing countries, but play a more limited role with regard to the potential redistribution of the benefits of research to the populations of these countries. We further suggest concrete initiatives that could facilitate the involvement of researchers from developing countries in the international genomics research community and accelerate capacity building in the developing world.

Two hundred and five newly assembled mitogenomes provide mixed evidence for rivers as drivers of speciation for Amazonian primates

“…Novel methods to extract nuclear data and even whole genomes from low‐quality or noninvasively collected samples are available (Burrell et al, 2015; Chiou & Bergey, 2018; Fontsere et al, 2021; Orkin et al, 2021), however, the costs associated with these methods, as well as their downstream computational requirements, remain prohibitive for many researchers, especially in primate host countries. While local capacity building should be a focus for genomicists working in the Global South (de Vries et al, 2015; Hetu et al, 2019; Rodríguez et al, 2005; Şekercioğlu, 2012), these efforts will take time, and until high‐throughput methods become more accessible, mitogenomics will continue to be a pillar of conservation genomics (Pomerantz et al, 2018; Watsa et al, 2020). Importantly, the novel mitogenomes assembled here have been made publicly available on GenBank along with important metadata, including sampling locations and voucher specimens, improving their utility and value for future analyses.…”

Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature

“…None of the reports were produced in lower-middle- and low-income countries. Typically, the public sector of these emerging markets have low access to innovative medical technologies, such as WGS, due to an inadequate number of equipped laboratories with the capacity to screen several individuals, the lack of health management information systems and, altogether, limited resources allocated to the public health system (30;31).…”

Bioinformática Aplicada Às Ciências Ômicas: Uma Breve Revisão Bibliográfica

“…Esses bancos de dados genômicos são considerados algumas das ferramentas de pesquisa mais importantes para o avanço científico no campo da genômica (HETU et al, 2019).…”